“Every CDMO is going to give you the Disney effect. I want to see what’s below the street. How is that organisation humming below the surface?” says John Philips, highlighting why superficial evaluations are undermining pharmaceutical outsourcing success. John Philips,
“Every minute, over 1000 patients are using a product manufactured in one of our sites,” reveals Kerstin Vieluf, Head of Sales at Recipharm. Headquartered in Stockholm, Sweden, Recipharm has over 5,900 employees across 17 sites in Europe, US, India, and
“I believe that if a quality culture is really embedded, the quality organisation starts reducing, because the more quality is embedded in the organisation, the less you need quality to help you think.” – Liesbeth Foesters Liesbeth Foesters, Vice President
Maurice van Rotterdam, Co-Founder of Netherlands-based digital marketing agency Sciential, believes many pharma suppliers and CDMOs are still missing the mark when it comes to effective digital marketing. “If I look at CDMO or pharma supplier websites, they typically have
An analysis of the CDMOs operating facilities in North America by Small Molecule, Biologics and Cell & Gene Therapy.
“Seven out of ten medicines dispensed in Europe are generic products. When we only look at price, we don’t take into consideration all the efforts European companies make on sustainability. This is an industry we must protect,” says Elisabeth Stampa,
“We can cut preclinical development from five years to 18 months. Molecules which are AI-enabled in some way seem to be doing better in Phase 1 than standard molecules.” – Dr. Eva-Maria Hempe, Head of Healthcare & Life Sciences EMEA
“You don’t just need to be good; you need to be better than others to drive your business,” warns Olaf Birkenmeier, Head of External Manufacturing at Polpharma Biologics, describing the evolutionary pressure facing Western biopharmaceutical manufacturers. Olaf Birkenmeier leads external
“Other CDMOs couldn’t handle these products, but we figured it out through technical grit and deep expertise,” explains Jackie Klecker, Executive Vice President of Quality and Development Services at Lifecore Biomedical. In a CDMO Live Preview episode of the PharmaSource
“Most founders dominate organisations, spending 70-hour weeks trying to control everything. But it’s not about the hours you work – it’s about the impact. That shift in mindset transformed how I built multiple successful businesses in pharma services,” explains Raman
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
